Xintela AB (OSTO:XINT) Short Interest

View and export this data going back to 2016. Start your Free Trial

What is Xintela AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Xintela AB's Short Interest

For the Biotechnology subindustry, Xintela AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xintela AB's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xintela AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Xintela AB's Short Interest falls into.

Xintela AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (OSTO:XINT) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

1XT:Germany

Address

Medicon Village, Lund, SWE, 22381

Website

http://www.xintela.se

Xintela AB is a biomedical company which utilises its proprietary marker technology XINMARK to develop stem cell-based therapies (XSTEM) for osteoarthritis and antibody-based therapies for Glioblastoma and Tripple-negative breast cancer. XSTEM is also evaluated for the treatment of the severe and deadly lung complication ARDS, which may affect covid-19 patients.

Xintela AB Headlines

No Headlines